DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line

Experimental Biology and Medicine

Volumn 238, Issue 9, 2013, Pages 1009-1016

  Konac, Ece ^a   Varol, Nuray ^a   Yilmaz, Akin ^a   Menevse, Sevda ^a   Sozen, Sinan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

catenin; apoptosis; DNA methylation; GSK3 ; RCC; sFRP2; Wnt antagonist

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; CASPASE 3; DICKKOPF 3 PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DNA METHYLATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

Β-CATENIN; APOPTOSIS; DNA METHYLATION; GSK3Β; RCC; SFRP2; WNT ANTAGONIST;

APOPTOSIS; AZACITIDINE; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEINS; HUMANS; WNT SIGNALING PATHWAY;

EID: 84884266957     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213498984     Document Type: Article

References (18)

1. Esteller M.Cancer epigenetics for the 21st century: what's next?.Genes Cancer. 2011;2:604-6.
2. Paul S,Dey A.Wnt signaling and cancer development: therapeutic implication.Neoplasma. 2008;55:165-76.
3. Saini S,Majid S,Dahiya R.The complex roles of Wnt antagonists in RCC.Nat Rev Urol. 2011;8:690-9.
4. Ueno K,Hirata H,Majid S,Chen Y,Zaman MS,Tabatabai ZL,Hinoda Y,Dahiya R.Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.Mol Carcinog. 2011;50:449-57.
5. Hirata H,Hinoda Y,Nakajima K,Kawamoto K,Kikuno N,Ueno K,Yamamura S,Zaman MS,Khatri G,Chen Y,Saini S,Majid S,Deng G,Ishii N,Dahiya R.Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.Int J Cancer. 2011;128:1793-803.
6. Kawakami K,Yamamura S,Hirata H,Ueno K,Saini S,Majid S,Tanaka Y,Kawamoto K,Enokida H,Nakagawa M,Dahiya R.Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.Int J Cancer. 2011;128:541-50.
7. Kawakami K,Hirata H,Yamamura S,Kikuno N,Saini S,Majid S,Tanaka Y,Kawamoto K,Enokida H,Nakagawa M,Dahiya R.Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.Cancer Res. 2009;69:8603-10.
8. Hirata H,Hinoda Y,Nakajima K,Kawamoto K,Kikuno N,Kawakami K,Yamamura S,Ueno K,Majid S,Saini S,Ishii N,Dahiya R.Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.Clin Cancer Res. 2009;15:5678-87.
9. Urakami S,Shiina H,Enokida H,Hirata H,Kawamoto K,Kawakami T,Kikuno N,Tanaka Y,Majid S,Nakagawa M,Igawa M,Dahiya R.Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.Clin Cancer Res. 2006;12:6989-97.
10. Shang D,Liu Y,Matsui Y,Ito N,Nishiyama H,Kamoto T,Ogawa O.Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.Urology. 2008;71:1220-5.
11. Kawamoto K,Hirata H,Kikuno N,Tanaka Y,Nakagawa M,Dahiya R.DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.Int J Cancer. 2008;123:535-42.
12. Fortmüller K,Alt K,Gierschner D,Wolf P,Baum V,Freudenberg N,Wetterauer U,Elsässer-Beile U,Bühler P.Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.Prostate. 2011;71:588-96.
13. Guillén-Ahlers H.Wnt signaling in renal cancer.Curr Drug Targets. 2008;9:591-600.
14. Awakura Y,Nakamura E,Ito N,Kamoto T,Ogawa O.Methylation-associated silencing of SFRP1 in renal cell carcinoma.Oncol Rep. 2008;20:1257-63.
15. Gumz ML,Zou H,Kreinest PA,Childs AC,Belmonte LS,LeGrand SN,Wu KJ,Luxon BA,Sinha M,Parker AS,Sun LZ,Ahlquist DA,Wood CG,Copland JA.Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.Clin Cancer Res. 2007;13:4740-9.
16. Steinhusen U,Badock V,Bauer A,Behrens J,Wittman-Liebold B,Dörken B,Bommert K.Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential.J Biol Chem. 2000;275:16345-53.
17. Luu HH,Zhang R,Haydon RC,Rayburn E,Kang Q,Si W,Park JK,Wang H,Peng Y,Jiang W,He TC.Wnt/beta-catenin signaling pathway as a novel cancer drug target.Curr Cancer Drug Targets. 2004;4:653-71.
18. Yeh CT,Yao CJ,Yan JL,Chuang SE,Lee LM,Chen CM,Yeh CF,Li CH,Lai GM.Apoptotic cell death and inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by an active fraction (HS7) from Taiwanofungus camphoratus.Evid Based Complement Alternat Med. 2011;2011:750230-750230.